Friday, January 28, 2022

The Morning: The new spy wars

A tale about Israel, Pegasus and the world.

Good morning. The Times has an inside look at the spyware that's changing cyberwar.

A Pegasus facility in Sapir, Israel.Amir Levy/Getty Images

The new espionage

When an Israeli company released a new spyware product known as Pegasus in 2011, it changed cyberwarfare. Pegasus could reliably decipher the communications of smartphones without the phone's user knowing and without the cooperation of AT&T, Apple or any other company.

Mexico's government bought Pegasus — from NSO Group, the Israeli start-up that created it — and used it to capture El Chapo, the drug lord. European investigators used the product to break up a child sex-abuse ring and stop terrorist plots.

But Pegasus also created some problems, and they quickly started becoming clear, too. Governments could use it to monitor and suppress critics and political opponents. Mexico was an example: It deployed the spyware not only against El Chapo but also against dissidents and journalists. Saudi Arabia and the United Arab Emirates used it against civil rights activists.

The F.B.I. bought a version of Pegasus in 2019, according to a new Times Magazine investigation by Ronen Bergman and Mark Mazzetti. Since then, U.S. officials across the Trump and Biden administrations have debated whether to use it within this country as well as abroad.

For now, the F.B.I. has decided not to do so. The Commerce Department went further, adding NSO to a list of foreign companies that it says jeopardize national security and preventing U.S. companies from working with it. Even so, the American government's copy of Pegasus continues to sit in a New Jersey office building, ready to be turned on if the federal government changes its policy.

Ronen's and Mark's story is full of other revelations, too:

  • Israel has used Pegasus as a diplomatic sweetener. It gave the U.A.E. and Bahrain access to it, which helped lead to the Abraham Accords, the 2020 pact in which the Arab countries normalized relations with Israel. At one point, Saudi Arabia's de facto leader, Crown Prince Mohammed bin Salman, threatened to block a crucial part of the deal unless Israel renewed Saudi Arabia's license to use Pegasus.
  • The C.I.A. bought a copy of Pegasus for Djibouti, to assist it in combating terrorism — despite the country's record of human rights abuses, including the torture of dissidents.
  • Pegasus has helped knit together right-wing nationalist governments around the world, with Hungary, India and Poland collaborating on its use. Benjamin Netanyahu, then Israel's prime minister, decided not to order Poland's Pegasus system to be cut off even after the country passed laws that many in Israel saw as Holocaust denial, and the Polish prime minister spoke of "Jewish perpetrators" of the genocide.

In addition to these fascinating details, the story underscores a larger point about cyberwarfare. As Ronen and Mark write:

Cyberweapons have changed international relations more profoundly than any advance since the advent of the atomic bomb. In some ways, they are even more profoundly destabilizing — they are cheap, easily distributed and can be deployed without consequences to the attacker. Dealing with their proliferation is radically changing the nature of state relations, as Israel long ago discovered and the rest of the world is now also beginning to understand.

More than 75 years after the invention of nuclear weapons, only nine countries appear to have a usable one. But dozens of countries already have cyberweapons. "Everybody seems to want them," Mark told me, "and this gives enormous power to the countries who sell them and can use them for diplomatic advantage."

It has also led to a huge increase in government spying, for good and for ill.

For more: Here are more highlights of the investigation.

THE LATEST NEWS

Politics
President Biden and Stephen Breyer at the White House.Sarahbeth Maney/The New York Times
Ukraine
Climate
Other Big Stories
School at home in Uttarakhand, India.Atul Loke for The New York Times
Opinions

Take exercise and health cues from your body, not your watch, Lindsay Crouse suggests.

Scholars who study the trans-Atlantic slave trade have an ethical duty: preserving the humanity of the enslaved, Jamelle Bouie argues.

Mandatory masking in schools should end once Omicron subsides, Michelle Goldberg argues.

Navigate your world with in-depth reporting.

Enjoy a more informed perspective with unlimited access to Times journalism. Subscribe now.

MORNING READS

An illustration of the James Webb Space Telescope.Adriana Manrique Gutierrez/NASA

Out there: The James Webb Space Telescope is a step toward humanity's ultimate quest.

"Do I need a toilet?": Crazy questions you ask yourself when looking for an apartment in New York.

"From worst to best": Step inside La Guardia Airport's gleaming new terminal.

Modern Love: His dating profile lacked a few crucial details.

Advice from Wirecutter: Smart home gadgets save money and energy.

Lives Lived: Dr. Johan Hultin was an intrepid pathologist who helped unlock the genetic sequence of the 1918 pandemic flu by finding victims preserved in permafrost. He died at 97.

SPORTS AND IDEAS

Roger Clemens intentionally walking Barry Bonds in 2004.Richard Carson/Reuters

A baseball debate goes on

Barry Bonds and Roger Clemens both failed to make the Baseball Hall of Fame this week, in their 10th and final year on the ballot. But the debate over their candidacies — both their undeniable statistical greatness and their presumed steroid use — is hardly over.

There are two paths to the Hall of Fame. In the first, sportswriters vote on candidates, and a player must receive at least 75 percent of the vote. Bonds received 66 percent this year, and Clemens 65 percent. The voters who kept them out of the Hall of Fame have, in effect, labeled them cheaters. In the second, a group called an era committee — composed mostly of Hall of Fame players and baseball executives — will evaluate players from 1988 onward. That group votes later this year.

Many writers, fans and players say Bonds and Clemens deserve to be inducted. For one thing, some current Hall members have their own history of cheating: Pitcher Gaylord Perry was inducted in 1991 despite doctoring baseballs, and for decades much of the league used amphetamine pills known as "greenies." For another, Bonds and Clemens weren't simply great players; they were among the best ever, dominating the sport at a time when many others used performance-enhancing drugs.

Some players accused of doping have already gotten in, including David Ortiz, who was elected this week. Others, such as Alex Rodriguez and Manny Ramirez, have not, though they remain on next year's ballot. — Matthew Cullen, a Morning writer

PLAY, WATCH, EAT

What to Cook
Andrew Scrivani for The New York Times

Make Suvir Saran's spinach and potato patties, or palak ki tikki.

What to Read

"Civil Rights Queen" is a major biography of Constance Baker Motley, the first Black woman to serve as a federal judge.

What to Listen to

Recordings of Brahms, Haydn and Grieg are among recent classical highlights.

Late Night

The hosts discussed Biden's Supreme Court strategy.

Take the News Quiz

How well did you follow this week's headlines?

Now Time to Play

The pangrams from yesterday's Spelling Bee were elementally and mentally. Here is today's puzzle — or you can play online.

Here's today's Mini Crossword, and a clue: Small battery size (three letters).

If you're in the mood to play more, find all our games here.

Thanks for spending part of your morning with The Times. See you Monday. — David

P.S. The Times has a new podcast with the creators of "Serial" and "S-Town," called "The Trojan Horse Affair." Here's a trailer.

"The Daily" is about the economy. On "Popcast," how a murder jolted Sweden's hip-hop scene.

Claire Moses, Ian Prasad Philbrick, Tom Wright-Piersanti, Ashley Wu and Sanam Yar contributed to The Morning. You can reach the team at themorning@nytimes.com.

Need help? Review our newsletter help page or contact us for assistance.

You received this email because you signed up for the Morning newsletter from The New York Times, or as part of your New York Times account.

To stop receiving these emails, unsubscribe or manage your email preferences.

Subscribe to The Times

Connect with us on:

facebooktwitterinstagram

Change Your EmailPrivacy PolicyContact UsCalifornia Notices

The New York Times Company. 620 Eighth Avenue New York, NY 10018

No comments:

Post a Comment